Next Article in Journal
Developing Clinically Relevant Dissolution Specifications for Oral Drug Products—Industrial and Regulatory Perspectives
Next Article in Special Issue
A Novel Testing Approach for Oxidative Degradation Dependent Incompatibility of Amine Moiety Containing Drugs with PEGs in Solid-State
Previous Article in Journal
Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure
Previous Article in Special Issue
Photostability of Topical Agents Applied to the Skin: A Review
Open AccessArticle

Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability

College of Pharmacy, Dankook University, 119, Dandae-ro, Dongnam-gu, Cheonan-si, Chungcheongnam-do 31116, Korea
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2020, 12(1), 18; https://doi.org/10.3390/pharmaceutics12010018
Received: 22 November 2019 / Revised: 18 December 2019 / Accepted: 20 December 2019 / Published: 23 December 2019
(This article belongs to the Special Issue Drug Stability and Stabilization Techniques)
A novel nanocrystal system of montelukast (MTK) was designed to improve the transdermal delivery, while ensuring chemical stability of the labile compound. MTK nanocrystal suspension was fabricated using acid-base neutralization and ultra-sonication technique and was characterized as follows: approximately 100 nm in size, globular shape, and amorphous state. The embedding of MTK nanocrystals into xanthan gum-based hydrogel caused little changes in the size, shape, and crystalline state of the nanocrystal. The in vitro drug release profile from the nanocrystal hydrogel was comparable to that of the conventional hydrogel because of the rapid dissolution pattern of the drug nanocrystals. The drug degradation under visible exposure (400–800 nm, 600,000 lux·h) was markedly reduced in case of nanocrystal hydrogel, yielding only 30% and 50% amount of cis-isomer and sulfoxide as the major degradation products, as compared to those of drug alkaline solution. Moreover, there was no marked pharmacokinetic difference between the nanocrystal and the conventional hydrogels, exhibiting equivalent extent and rate of drug absorption after topical administration in rats. Therefore, this novel nanocrystal system can be a potent tool for transdermal delivery of MTK in the treatment of chronic asthma or seasonal allergies, with better patient compliance, especially in children and elderly. View Full-Text
Keywords: montelukast; nanocrystal suspension; transdermal delivery; nanocrystal hydrogel; photo-stability montelukast; nanocrystal suspension; transdermal delivery; nanocrystal hydrogel; photo-stability
Show Figures

Graphical abstract

MDPI and ACS Style

Im, S.H.; Jung, H.T.; Ho, M.J.; Lee, J.E.; Kim, H.T.; Kim, D.Y.; Lee, H.C.; Choi, Y.S.; Kang, M.J. Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability. Pharmaceutics 2020, 12, 18.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop